Research and Markets: Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7n6xpp/chemotherapy) has announced the addition of Global Markets Direct's new report "Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2012" to their offering.

“Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2012”

This report provides information on the therapeutic development for Chemotherapy Induced Peripheral Neuropathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Peripheral Neuropathy. Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, Half Year is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Chemotherapy Induced Peripheral Neuropathy.

- A review of the Chemotherapy Induced Peripheral Neuropathy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Chemotherapy Induced Peripheral Neuropathy pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Involved in Chemotherapy Induced Peripheral Neuropathy Therapeutics Development:

- Sigma-Tau S.p.A.

- EpiCept Corporation

- Spectrum Pharmaceuticals, Inc.

- CeNeRx BioPharma, Inc.

- Spinifex Pharmaceuticals Pty Limited

For more information visit http://www.researchandmarkets.com/research/7n6xpp/chemotherapy

Source: Global Markets Direct